Arzneimittel-Forschung 1995-06-01

Determination of the new fluoroquinolone balofloxacin and its metabolites in biological fluids by high performance liquid chromatography.

T Nakagawa, M Ishigai, Y Hiramatsu, H Kinoshita, Y Ishitani, K Ohkubo, A Okazaki

Index: Arzneimittelforschung 45(6) , 716-8, (1995)

Full Text: HTML

Abstract

A sensitive high performance liquid chromatographic method for the determination in biological fluids of 1-cyclopropyl-6-fluoro-1,4- dihydro-8-methoxy-7-(3-methylaminopiperidin-1-yl)-4-oxoquinoline-3 -carboxylic acid dihydrate (CAS 127294-70-6, balofloxacin, Q-35), a new fluoroquinolone, as well as its metabolites, has been developed. Balofloxacin and its metabolite, N-desmethyl balofloxacin, were separated and determined by reversed-phase column with fluorescence detection. Balofloxacin glucuronide was determined as balofloxacin after alkali hydrolysis. This method exhibited good precision and accuracy. Furthermore, it is a simple method and requires only a small amount of samples, and therefore should be useful for pharmacokinetic studies in animals and humans.

Related Compounds

Related Articles:

Photoallergenicity of a fluoroquinolone antibacterial agent with a fluorine substituent at the 8-position in guinea pigs exposed to long-wavelength UV light.

1998-01-01

[Skin Pharmacol. Appl. Skin Physiol. 11(4-5) , 232-40, (1998)]

Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis.

2009-01-01

[Ophthalmic Res. 42(1) , 43-8, (2009)]

Alterations of protein complexes and pathways in genetic information flow and response to stimulus contribute to Escherichia coli resistance to balofloxacin.

2012-09-01

[Mol. Biosyst. 8(9) , 2303-11, (2012)]

High performance liquid chromatography-electrospray ionization mass spectrometric determination of balofloxacin in human plasma and its pharmacokinetics.

2007-05-01

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 850(1-2) , 68-73, (2007)]

In vitro and in vivo antibacterial activities of Q-35, a novel fluoroquinolone.

1995-01-01

[Chemotherapy 41(2) , 100-12, (1995)]

More Articles...